Abstract
Purpose
The currently recommended treatment strategy for cystine stone formers is based on a progressive approach that starts with the most conservative measures. In patients with cystinuria, increased patient compliance with dietary management and medical treatment is associated with fewer stone interventions. In this case-based review, the dietary management of cystine stone former was reviewed under the guidance of evidence-based medicine.
Methods
The dietary management of the 13-year-old cystinuria patient, who underwent 18 endourological stone interventions, was reviewed in the light of evidence-based medicine. A literature search was performed in Pubmed, MEDLINE, Embase, and Cochrane Library databases according to PRISMA guidelines published from 1993 to September 2022. A total of 304 articles were included in this paper.
Results
In managing patients with cystinuria, hyperhydration, and alkalinization of the urine with medical treatment, the rational use of cystine-binding drugs by taking into account individual situations has come to the fore. A limited study has argued that a vegetarian diet is effective as the alkaline load from fruits and vegetables can reduce the amount of alkalizing substances required to achieve urinary alkalinization above pH 7.5, making it particularly suitable for the dietary treatment of cystine stone disease.
Conclusion
Life-long follow-up with dietary modification, hyperhydration, and personalized medical therapy (alkalinization and cystine-binding drugs) are critical in preventing chronic kidney disease and kidney failure in cystinuria.
Similar content being viewed by others
Data availability
No data was used for the research described in the article.
References
Wollaston WH (1810) XIII. On cystic oxide, a new species of urinary calculus. Philos Trans R Soc Lond 100:223–230
Chillarón J, Font-Llitjós M, Fort J, Zorzano A, Goldfarb DS, Nunes V, Palacín M (2010) Pathophysiology and treatment of cystinuria. Nat Rev Nephrol 6(7):424–434
Sumorok N, Goldfarb DS (2013) Update on cystinuria. Curr Opin Nephrol Hypertens 22(4):427
Knoll T, Zöllner A, Wendt-Nordahl G, Michel MS, Alken P (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20(1):19–24
Kowalczyk NS, Zisman AL (2021) Focus: rare disease: cystinuria: review of a life-long and frustrating disease. Yale J Biol Med 94(4):681
Servais A, Thomas K, Strologo LD, Sayer JA, Bekri S, Bertholet-Thomas A et al (2021) Cystinuria: clinical practice recommendation. Kidney Int 99(1):48–58
Rogers A, Kalakish S, Desai RA, Assimos DG (2007) Management of cystinuria. Urol Clin North Am 34(3):347–362
Font-Llitjos M, Jimenez-Vidal M, Bisceglia L, Di Perna M, De Sanctis L, Rousaud F et al (2005) New insights into cystinuria: 40 new mutations, genotype–phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet 42(1):58–68
Strologo LD, Pras E, Pontesilli C, Beccia E, Ricci-Barbini V, De Sanctis L et al (2002) Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol 13(10):2547–2553
Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38(3):147–160
Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Worcester AM (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69(12):2227–2235
Nagamori S, Wiriyasermkul P, Guarch ME, Okuyama H, Nakagomi S, Tadagaki K et al (2016) Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1. Proc Natl Acad Sci 113(3):775–780
Prot-Bertoye C, Daudon M, Tostivint I, Dousseaux MP, Defazio J, Traxer O et al (2021) Cystinurie. Nephrol Ther 17:S100–S107
Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Jais JP, Lillo-Le Louët A et al (2019) Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France. BJU Int 124(5):849–861
Worcester EM, Coe FL, Evan AP, Parks JH (2006) Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int 97(6):1285–1290
Thomas JC, DeMARCO RT, Donohoe JM, Adams MC, Brock JW, Pope JC (2005) Pediatric ureteroscopic stone management. J Urol 174(3):1072–1074
Andreassen KH, Pedersen KV, Osther SS, Jung HU, Lildal SK, Osther PJS (2016) How should patients with cystine stone disease be evaluated and treated in the twenty-first century? Urolithiasis 44(1):65–76
Nakagawa Y, Coe FL (1999) A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin Chim Acta 289(1–2):57–68
Warren H, Poon D, Srinivasan R, Thomas K, Rottenberg G, Bultitude M, Thomas K (2021) Non-contrast computed tomography characteristics in a large cohort of cystinuria patients. World J Urol 39(7):2753–2757
Grases F, Costa-Bauza A, Prieto RM (2006) Renal lithiasis and nutrition. Nutr J 5(1):1–7
Ljunghall S, Hedstrand H (1975) Epidemiology of renal stones in a middle-aged male population. Acta Med Scand 197(6):439–445
Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S et al (2016) Kidney stones. Nat Rev Dis Primers 2(1):1–23
Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR et al (2009) Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 56(1):72–80
Pietrow PK (2007) Evaluation and medical management of urinary lithiasis. Campbell-Walsh Urol 9th ed. Philadelphia PA: Saunders, 1393–1430
Heilberg IP, Goldfarb DS (2013) Optimum nutrition for kidney stone disease. Adv Chronic Kidney Dis 20(2):165–174
Porena M, Guiggi P, Micheli C (2007) Prevention of stone disease. Urol Int 79(Suppl. 1):37–46
Barbey F, Joly D, Rieu P, Méjean A, Daudon M, Jungers P (2000) Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 163(5):1419–1423
Kolb FO, Earll JM, Harper HA (1997) “Disappearance” of cystinuria in a patient treated with prolonged low methionine diet. Metabolism 16(4):378–381
Lindell Å, Denneberg T, Edholm E, Jeppsson JO (1995) The effect of sodium intake on cystinuria with and without tiopronin treatment. Nephron 71(4):407–415
Fjellstedt E, Denneberg T, Jeppsson JO, Tiselius HG (2001) A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria. Urol Res 29(5):295–302
Mattoo A, Goldfarb DS (2008) Cystinuria. Seminars Nephrol 28(2):181–191 (WB Saunders)
Biyani CS, Cartledge JJ (2006) Cystinuria—diagnosis and management. EAU-EBU Update Ser 4(5):175–183
Saravakos P, Kokkinou V, Giannatos E (2014) Cystinuria: current diagnosis and management. Urology 83(4):693–699
Crawhall JC, Scowen EF, Watts RWE (1993) Effect of penicillamine on cystinuria. BMJ 1(5330):588
Dahlberg PJ, Kurtz SB, Wilson DM, Smith LH (1997) Clinical features and management of cystinuria. Mayo Clin Proc 52(9):533–542
Chow GK, Streem SB (1996) Medical treatment of cystinuria: results of contemporary clinical practice. J Urol 156:1576–1578
Knoll T, Zöllner A, Wendt-Nordahl G, Michel MS, Alken P (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20:19–24
Pak CY, Fuller C, Sakhaee K, Zerwekh JE, Adams BV (1996) Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol 136:1003–1008
Barbey F, Joly D, Rieu P, Méjean A, Daudon M, Jungers P (2000) Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 163:1419–1423
Cohen TD, Streem SB, Hall P (1995) Clinical effect of captopril on the formation and growth of cystine calculi. J Urol 154:164–166
Weigert A, Hoppe B (2018) Nephrolithiasis and nephrocalcinosis in childhood-risk factor-related current and future treatment options. Front Pediatr 6:98
Author information
Authors and Affiliations
Contributions
HU: literature search, project development, data collection, analysis and interpretation, manuscript writing/editing; MGS: analysis and interpretation, manuscript writing/editing; SG: critical revision, project development, data collection, analysis and interpretation, manuscript writing/editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no confict of interest.
Research involving human participants and/or animals
No human subjects or animals were involved in this study.
Informed consent
Due to the nature of this article, acquisition of informed consent is not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ucmak, H., Sonmez, M.G. & Guven, S. Case-based review of dietary management of cystinuria. World J Urol 41, 1215–1220 (2023). https://doi.org/10.1007/s00345-022-04263-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-022-04263-1